[JANX] QoQ Quarter Result on 30-Jun-2021 [#Q2]

Stock
[JANX] Janux Therapeutics, Inc.
Announcement Date
10-Aug-2021
Financial Year
2021
Quarter
30-Jun-2021 [#Q2]
Profit Trend
QoQ- -171.72%
YoY- -152.28%
Quarter Report
JANX's Result
JANX's Financial Summary
View:
Show?
Quarter Result
31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 30/09/20 CAGR
Revenue 1,589 1,616 1,159 482 380 0 0 -
PBT -13,410 -13,416 -10,766 -6,206 -2,284 -1,655 -1,256 385.57%
Tax -264 -74 137 46 0 0 0 -
NP -13,146 -13,416 -10,766 -6,206 -2,284 -1,655 -1,256 379.17%
Tax Rate - - - - - - - -
Total Cost 14,735 15,032 11,925 6,688 2,664 1,655 1,256 417.08%
Ratio Analysis
31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 30/09/20 CAGR
NP Margin -827.31 -830.20 -928.90 -1,287.55 -601.05 0.00 0.00 -
Per Share
31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 30/09/20 CAGR
EPS -0.32 -0.33 -0.26 -0.62 -0.06 -0.13 -0.10 117.30%
EPS Diluted -0.32 -0.33 -0.26 -0.62 -0.06 -0.13 -0.10 117.30%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.